NCDSER Purchases Instem’s Provantis Preclinical Software Suite
7/16/2014 9:13:39 AM
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that the National Shanghai Center for Drug Safety Evaluation and Research (NCDSER), also known as Shanghai InnoStar Bio-Tech Co. Ltd., has purchased the Provantis® preclinical software suite to automate laboratory processes at their R&D facility in the Zhangjiang Hi-Tech Park, Pudong, Shanghai, China.
Help employers find you! Check out all the jobs and post your resume.
comments powered by